A solutions-based approach to innovation, Abbott’s EP portfolio is designed to improve your procedure experience. Our approach to technology helps physicians deliver better outcomes faster by focusing on three key factors:
Efficiency is not just about reduction in procedure times. Bold technology should also promise less repeat procedures and reduced all-cause events. Advisor™ HD Grid Mapping Catheter has shown a 14% reduction in redo procedures compared to CMCs2 and TactiCath™ Ablation Catheter, SE results in decreased healthcare utilization by reducing all-cause annual event rates by more than 53%3
Boldness in treating AFib requires technology that never sacrifices accuracy or efficiency. Abbott’s EP portfolio delivers both.
EnSite™ X Software Verson 2 provides a more accurate mapping experience by automatically removing outliers.
Accurate contact force matters during your ablation procedures. TactiCath™ Contact Force Catheter, Sensor Enabled™ has shown 6x greater accuracy in lateral orientation for contact force ablation than the competition.6,7
Your end goal is for your patients to be well. Abbott’s focus on creating technologies that are efficient and accurate gives you the tools you need to boldly redefine patient outcomes and change your patients’ lives. Bold solutions to challenge AFib is –
12-month freedom from atrial arrhythmias with Advisor HD Grid Mapping Catheter, Sensor Enabled1
Freedom of arrhythmia at 12 months with Agilis NxT Steerable Sheath9
% of patients reporting improved quality of life at 12 months following ablation11
Ischemic stoke rate reduced by 67% compared to predicted risk12
With the Amplatzer™ Amulet™ Left Atrial Appendage Occluder (LAAO) you do both – not only delivering a 67% lower stroke rate, but also allowing 8 out of 10 patients to be discharged without OACs.12 Amplatzer Amulet LAAO is the only FDA-approved LAAO that does not require use of OACs at discharge.
Clinical support that elevates your
practice to meet today's challenges
Partnerships that drive
impact for the EP community
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?